Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies Jui-Hsiang Hung; Chiao-Feng Teng; Hsu-chin Hung; Yi-Lin Chen; Pin-Jun Chen; Chung-Liang Ho; Cheng-Hsiang Chuang; Wenya Huang;

From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico Piñero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;